Debevoise Advises J.P. Morgan as Financial Advisor to Allergan in the Sale of its Generics Unit to Teva for $40.5 Billion

27 July 2015

Debevoise & Plimpton LLP is advising J.P. Morgan Securities (“J.P. Morgan”) as financial advisor to Allergan plc (“Allergan”) in the sale of its generics unit to Teva Pharmaceutical Industries Ltd. (“Teva”) for $40.5 billion in cash and Teva shares.

The Debevoise team is led by partner Andrew L. Bab and includes associates Zhiyan Cao and Pankita D. Naik.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.